Outcomes of systemic therapy in metastatic phyllodes tumor of the breast.

Amanda ParkesWei-Lien WangShreyaskumar PatelCheuk Hong LeungHeather LinAnthony P ConleyNeeta SomaiahDejka M AraujoMaria ZarzourJohn Andrew LivingstonJoseph LudwigChristina L RolandVinod RaviRobert S BenjaminRavin Ratan

Published in: Breast cancer research and treatment (2021)

MPT patients are a unique population with limited characterization to date. Our study demonstrates activity of multiple sarcoma-directed chemotherapy regimens, with ifosfamide-containing regimens having the longest PFS.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
squamous cell carcinoma
small cell lung cancer
peritoneal dialysis
prognostic factors
type diabetes
stem cells
patient reported outcomes
locally advanced
mesenchymal stem cells
adipose tissue
weight loss
smoking cessation